There is evidence that NEK6 is increased in several malignant human cancer cells including breast, colon, lung, kidney, rectum, thyroid, ovarian, prostate, pancreas and small intestine cancers, and correlates with patient clinical prognosis (He et al., 2018; Choudhury et al., 2017; Panchal and Evan Prince, 2023; Gao et al., 2025). This evidence concerns the gene NEK6 and cancer.